Gland Pharma cracks day after company signs pact to buy Europe-based Cenexi
Gland Pharma Share Price NSE: Brokerages have given a mixed response on the stock post announcement of the agreement
Gland Pharma Share Price NSE: Shares of Gland Pharma Ltd, NSE: GLAND, cracked nearly 4 per cent on Wednesday, November 30. The downtrend in stock came on the back of the company's wholly-owned Singapore-based unit Gland Pharma International PTE entering into a 'Put Option Agreement' to acquire 100 per cent of Cenexi Group for an equity value not exceeding EUR 120 million. Cenexi Group is a Hyderabad based drug contract development and manufacturing company.
The counter opened at Rs 1,878 on NSE and cracked more than 4 per cent to quote Rs 1,799.10 at 11:40 AM.
Brokerages have given a mixed response on the stock post announcement of the agreement.
Zee Business panellist and technical analyst Simi Bhaumik recommended the stock for long-term investment. For short-term investors, she said that the target would be Rs 2000-2050 and stop loss would be at Rs 1900.
"Once can expect a rally towards Rs 2500 if the stock holds the level of 1900. The stop loss for long term investors would be at Rs 1600," she said.
Market analyst Ambareesh Baliga said that the stock has corrected and bottomed up. He said that the scrip could slip into a consolidate phase at current price.
Meanwhile, reacting to the proposed acquisition, Gland Pharma MD & CEO Srinivas Sadu said that this would be the company's first international acquisition and it would "perfectly support our goal of deepening access into the European markets".
"This acquisition would help expand our global presence and further solidify our identity as an injectable focused CDMO company," Sadu said.
Gland Pharma Share Price History
Gland Pharma stock has tanked 53 per cent in 2022 so far. At current level, the company has a market cap of Rs 29.64 thousand crore. The stock's 52-week range is Rs 4,062.95 - Rs 1,660.00.
Click Here For Latest Updates On Stock Market | Zee Business Live
Stocks to buy: Ashok Leyland, Dr Lal PathLabs among 5 Shares with an upside potential of 39% return
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits
Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?
EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know
Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404
01:13 PM IST